simulationName;Larson_2013_8y-18y_400mg_FCT_meal;Larson_2013_8y-18y_400mg_FCT_meal;Larson_2013_8y-18y_400mg_FCT_meal;Larson_2013_8y-18y_400mg_FCT_meal;Larson_2013_8y-18y_400mg_FCT_meal;R-square;pValue;Filmcoated_tablet_400mg_sd;Filmcoated_tablet_400mg_sd;Filmcoated_tablet_400mg_sd;Filmcoated_tablet_400mg_sd;Filmcoated_tablet_400mg_sd
;5^{th}-Individual ID 72;5^{th}-Individual ID 72;5^{th}-Individual ID 72;5^{th}-Individual ID 72;5^{th}-Individual ID 72;;;95^{th}-Individual ID 76;95^{th}-Individual ID 76;95^{th}-Individual ID 76;95^{th}-Individual ID 76;95^{th}-Individual ID 76
;Lipophilicity;Specific intestinal permeability (transcellular);Raltegravir-UGT1A9-Kassahun 2007|In vitro Vmax for liver microsomes;Raltegravir-UGT1A1-Kassahun 2007|In vitro Vmax for liver microsomes;Dissolution shape;;;Lipophilicity;Specific intestinal permeability (transcellular);Raltegravir-UGT1A9-Kassahun 2007|In vitro Vmax for liver microsomes;Raltegravir-UGT1A1-Kassahun 2007|In vitro Vmax for liver microsomes;Dissolution shape
;-0.140617164260662;-0.0351951595009153;-0.066265806204967;-0.126498734950565;-0.107606005750141;;;0.338016455023075;-0.139326474027847;0.00485047885638425;0.112874653160673;0.120975620158601
;-0.144404749455008;-0.0398281608845343;-0.0681899433558365;-0.137032401113205;-0.115241255606181;;;0.296071655017939;-0.175914683835179;0.00314863024955367;0.111165273952657;0.115468434741572
;-0.136829579066316;-0.0305621581172963;-0.0643416690540974;-0.115965068787925;-0.0999707558941011;;;0.379961255028212;-0.102738264220514;0.00655232746321483;0.114584032368688;0.12648280557563
;0.999785140820905;0.994893367499702;0.999750320023659;0.997950279121248;0.998510894808681;;;0.995459504464886;0.979981479292349;0.964818267836011;0.999932071259934;0.999386525863815
;1.33674241361608e-06;0.000155116294036592;1.67454556441035e-06;3.94092543157754e-05;2.43989453910018e-05;;;0.000130027842243774;0.0012093872465048;0.00283081781741568;2.3761729826801e-07;6.45005173436669e-06
